Back to search

University of British Columbia

Using magnetic resonance imaging and immunohistochemistry to monitor the response of HCT-116 xenograft tumours to tirapazamine

Abstract

dc:description

Tirapazamine is a prodrug which is activated under hypoxic conditions and has shown promise in treating hypoxic tumours. Using MRI and histochemistry, the response of HCT116 xenograft tumours to tirapazamine was investigated and quantified. Dynamic contrast-enhanced and diffusion weighted MRI scans were acquired both before and after treatment with tirapazamine in under two hours of imaging time per session. MRI data was used to produce maps of the apparent diffusion coefficient (ADC), area-under-the-curve (IAUC), and pharmacokinetic parameters (Ktrans, ve, vv). Carbocyanine and BrdU/haematoxylin staining were used to produce histological images of perfusion and necrosis. Implanted fiducial markers were used to align MRI data before and after treatment, and to align MRI slices with histological sections. Qualitative and quantitative comparisons between MRI and histological images showed good agreement between the two. Data from both modalities showed that tirapazamine causes significant changes in diffusion and decreases in perfusion within 24 hours after treatment; widespread vascular shutdown and central necrosis were observed in treated tumours. The agreement of dynamic contrast-enhanced MRI and diffusion weighted MRI with accepted immunohistochemical methods suggests that the MRI techniques presented here are effective methods of monitoring the response of hypoxic, heterogeneous tumours to treatment with tirapazamine. This is the first MR investigation to measure the effects of tirapazamine in an in vivo tumour model. The non-invasive imaging protocol developed here has the potential for direct translation to the clinic in a potential trial. Interestingly, the response of tumours to tirapazamine is evidenced by marked vascular shutdown detected using dynamic contrast enhanced MR imaging, supporting the hypothesis that tirapazamine's mechanism of action may include vascular effects.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Physics
Grantor dc:publisher
University of British Columbia
Year dc:date
2007

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Bains, Lauren Jean

Rights

dc:rights
Statement dc:rights
  • For non-commercial purposes only, such as research, private study and education. Additional conditions apply, see Terms of Use https://open.library.ubc.ca/terms_of_use.
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/31832

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Bains, Lauren Jean. Using magnetic resonance imaging and immunohistochemistry to monitor the response of HCT-116 xenograft tumours to tirapazamine. master's thesis, University of British Columbia, 2007. http://hdl.handle.net/2429/31832